EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis

Karthikah Jeganathan iD, Fabiola Ceroni iD, Samuel J H Clokie, Nicole Motton Hill, Manoj Parulekar, Karl Johnson, Lidiya V Talbot iD, Dorine A Bax, Nicola K Ragge iD

Clinical Genetics · 29.10.2026

DOI: 10.1111/cge.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 29.10.2026. Verfasst von Karthikah Jeganathan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, Science and Technology (HST), Oxford Brookes University, Oxford, UK. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baillie Gifford, Microphthalmia, Anophthalmia and Coloboma Support (MACS) Charity, National Institute for Health and Care Research (NIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mosaic RASopathies are a group of rare developmental disorders arising from post‐zygotic variants in members of the RAS/MAPK signalling pathway and with a cancer predisposition. Their phenotypic manifestations are highly variable and depend on the extent and distribution of tissue involvement. Ocular features typically include epibulbar dermoids, although structural eye anomalies are also less commonly reported. We describe a girl with microphthalmia and coloboma whose extraocular features were suggestive of the mosaic RASopathy, EncephaloCranioCutaneous Lipomatosis (ECCL). Genetic analyses of affected tissues revealed a missense variant in the RAS pathway gene KRAS (p.[Ala146Pro]), located in a recurrent hotspot for mosaic RASopathies. The variant was absent in blood, confirming a tissue‐restricted distribution. The identification of this mosaic KRAS variant genetically confirmed the clinical diagnosis of ECCL and prompted appropriate tumour surveillance. This case highlights mosaic RASopathies as a cause of developmental eye anomalies.

Schlagwörter

Stichwörter der Autor:innen

KRASEncephaloCranioCutaneous Lipomatosis (ECCL)microphthalmiamosaic RASopathymosaicism

Autor:innen und Institutionen

  • Faculty of Health, Science and Technology (HST), Oxford Brookes University, Oxford, UK.
  • Nonacus Clinical Services, Quinton Business Park, Quinton, Birmingham, UK.
  • West Midlands Regional Genetics Laboratories, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Eye Department, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Eye Department, Oxford University Hospitals, Oxford, UK.
  • Radiology Department, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

ORCID-Profile: Karthikah Jeganathan, Fabiola Ceroni, Lidiya V Talbot, Nicola K Ragge

Förderung

  • Baillie Gifford
  • Microphthalmia, Anophthalmia and Coloboma Support (MACS) Charity
  • National Institute for Health and Care Research (NIHR)
  • Vinchel Foundation

Zitieren

APA

Jeganathan, K., Ceroni, F., Clokie, S. J. H., Motton Hill, N., Parulekar, M., Johnson, K., Talbot, L. V., Bax, D. A., & Ragge, N. K. (2026). Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis. Clinical Genetics. https://doi.org/10.1111/cge.70274

Vancouver

Jeganathan K, Ceroni F, Clokie SJH, Motton Hill N, Parulekar M, Johnson K, et al. Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis. Clinical Genetics. 2026. doi:10.1111/cge.70274

BibTeX
@article{Jeganathan2026,
  author = {Jeganathan, Karthikah and Ceroni, Fabiola and Clokie, Samuel J H and Motton Hill, Nicole and Parulekar, Manoj and Johnson, Karl and Talbot, Lidiya V and Bax, Dorine A and Ragge, Nicola K},
  title = {Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis},
  journal = {Clinical Genetics},
  year = {2026},
  doi = {10.1111/cge.70274}
}
Kostenlos starten →